Blank Rome Represents Intricon Corporation in Its $241M Take-Private Acquisition by Altaris Capital Partners
A Blank Rome team represented longstanding firm client Intricon Corporation, an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable, and body-worn medical devices, in its $241 million take-private acquisition by Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry. The transaction closed on May 24, 2022.
For more information, please read Altaris Capital Partners’ $241 Million Acquisition of Intricon Corporation (Global Legal Chronicle, May 27, 2022).
The Blank Rome team was led by Francis E. Dehel and Yelena M. Barychev, with substantial assistance from Emma T. Pachon and John A. Meehan. Also assisting were Riley Bauer, Kipp B. Cohen, Andrew T. Hambelton, Michael A. Kadlec, Evan H. Lechtman, Jeffrey M. Rosenfeld, Elaine D. Solomon, Megan E. Spitz, Elizabeth V. Young, and Ivy Shapiro.